Proteome Sciences PLC (PRM)
Industry Diagnostics & Research
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
3.50p
Buy
3.90p
0.64p (+19.63%)
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for prognostic and therapeutic applications.
Prices updated at 16 May 2025, 16:35 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Christopher Donovan James Pearce
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
31
Head office
Downside Bridge Road
Cobham
United Kingdom
KT11 3EP
Key personnel
Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
---|---|---|---|---|---|
Mr. Roger Steven McDowell Non-Executive Director | - | - | - | 0.04m | - |
Mr. Martin Henry Diggle Non-Executive Director | - | - | - | - | - |
Dr. Ian Pike Executive Director, Chief Scientific Officer | - | - | - | - | - |
Mr. Richard Paul Dennis Executive Director, Chief Commercial Officer | - | - | - | - | - |
Mr. Christopher Donovan James Pearce Executive Director, Chairman | - | - | - | 0.06m | - |
Top 5 shareholders
Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
---|---|---|---|---|---|---|
No data |
Director dealings
Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
---|---|---|---|---|---|---|---|
No data |
Please note that past performance is not a reliable indicator of future returns.